flutamide has been researched along with estramustine in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (27.27) | 18.7374 |
| 1990's | 14 (42.42) | 18.2507 |
| 2000's | 6 (18.18) | 29.6817 |
| 2010's | 4 (12.12) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Merrin, CE; Murphy, GP | 1 |
| Müntzing, J; Murphy, GP; Saroff, J; Varkarakis, MJ | 1 |
| Sandberg, AA | 1 |
| Müntzing, J; Murphy, GP; Myhrberg, H; Sandberg, AA; Saroff, J | 1 |
| Schmidt, JD | 1 |
| Curley, T; Dershaw, DD; Petrylak, D; Scher, HI; Seidman, AD | 1 |
| Kastelan, M; Kraljić, I; Tarle, M | 1 |
| Long, JP; Prout, GR | 1 |
| Ameye, F; Baert, L; Oyen, R; Van De Voorde, W; Van Poppel, H | 1 |
| Radoś, N; Tarle, M | 1 |
| Fischer, M; Flamm, J | 1 |
| Andersson, SO; Beckman, KW; Johansson, JE; Zador, G | 1 |
| de Kernion, JN; Murphy, GP; Priore, R | 1 |
| Andersson, SO; Beckman, KW; Johansson, JE; Lingårdh, G; Zador, G | 1 |
| Fosså, SD; Paus, E | 1 |
| Baert, LV; Elgamal, AA; Lauweryns, JM; Van de Voorde, WM; Van Poppel, HP; Verbeken, EK | 1 |
| Brogden, RN; Faulds, D | 1 |
| Atkins, CD | 1 |
| Hinke, A; Roessler, W; Wieland, WF | 1 |
| Hachiya, T; Okada, K | 1 |
| Denis, L | 1 |
| Akaza, H; Tsukamoto, S | 1 |
| Budman, DR; Kreis, W; Liu, XM; Wang, LG | 1 |
| Köhn, FM; Meineke, V; Pickl, U; Ring, J; Vogt, HJ | 1 |
| Itoh, K; Noda, S; Noguchi, M; Shiraishi, T; Ueda, S; Yoshida, M | 1 |
| Slovin, SF | 1 |
| Aguilera Tubet, C; Ballestero Diego, R; Roca Edreira, A; Villanueva Peña, A; Zubillaga Guerrero, S | 1 |
| Bastide, C; Bruyère, F; Guy, L; Karsenty, G; Rozet, F | 1 |
7 review(s) available for flutamide and estramustine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Potential test systems for chemotherapeutic agents against prostatic cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Animals; Antineoplastic Agents; Arginase; Dihydrotestosterone; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Estradiol; Estramustine; Estriol; Estrogens; Flutamide; Haplorhini; Humans; Male; Mice; Neoplasms, Experimental; Prostate; Prostatic Neoplasms; Rats; Testosterone | 1975 |
Chemotherapy of prostatic cancer.
Topics: Aged; Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Bromocriptine; Cyproterone; Depression, Chemical; Diethylstilbestrol; Drug Therapy, Combination; Estramustine; Fluorouracil; Flutamide; Health Facilities; Hematologic Diseases; Humans; Kinetics; Male; Mitosis; Nitrogen Mustard Compounds; Prostatic Neoplasms | 1975 |
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in prostate cancer.
Topics: Absorption; Aged; Antineoplastic Combined Chemotherapy Protocols; Estramustine; Estrogens; Flutamide; Gonadotropins; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms; Steroids | 1995 |
[Significance of neoadjuvant therapy for prostate cancer].
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Diethylstilbestrol; Estramustine; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Prostatectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic | 1997 |
[Progress in oral anti-cancer drug therapy for urological cancer].
Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Drug Combinations; Estramustine; Etoposide; Female; Flutamide; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1999 |
[Hormonal treatment in prostate cancer].
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Antineoplastic Agents, Hormonal; Benzamides; Combined Modality Therapy; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Estrogens, Non-Steroidal; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazolidines; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Oligopeptides; Phenylthiohydantoin; Prostatectomy; Prostatic Neoplasms | 2013 |
9 trial(s) available for flutamide and estramustine
| Article | Year |
|---|---|
Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer.
Topics: Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Diethylstilbestrol; Estramustine; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Vinblastine | 1992 |
[Complete androgen blockade (orchiectomy + flutamide) versus androgen blockade with cytostasis (orchiectomy + estramustine) in the treatment of virginal advanced prostate cancer].
Topics: Aged; Aged, 80 and over; Anilides; Clinical Trials as Topic; Combined Modality Therapy; Estramustine; Flutamide; Humans; Male; Middle Aged; Neoplasm Metastasis; Nitrogen Mustard Compounds; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Random Allocation | 1988 |
Clinical evaluation with long-term follow-up of flutamide and estramustine as initial treatment of metastatic carcinoma of the prostate.
Topics: Adenocarcinoma; Aged; Anilides; Bone Neoplasms; Estramustine; Flutamide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitrogen Mustard Compounds; Prospective Studies; Prostatic Neoplasms; Random Allocation; Time Factors | 1988 |
Comparison of flutamide and Emcyt in hormone-refractory metastatic prostatic cancer.
Topics: Anilides; Carcinoma; Clinical Trials as Topic; Estramustine; Flutamide; Hematologic Diseases; Humans; Male; Nausea; Nitrogen Mustard Compounds; Prospective Studies; Prostatic Neoplasms; Random Allocation; Vomiting | 1988 |
Clinical evaluation of flutamide and estramustine as initial treatment of metastatic carcinoma of prostate.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anilides; Bone Neoplasms; Estramustine; Flutamide; Humans; Libido; Male; Middle Aged; Nitrogen Mustard Compounds; Prostatic Neoplasms; Random Allocation; Time Factors | 1987 |
Reduction of serum prostate-specific antigen during endocrine or cytotoxic treatment of hormone-resistant cancer of the prostate. A preliminary report.
Topics: Aged; Biomarkers, Tumor; Combined Modality Therapy; Epirubicin; Estramustine; Flutamide; Humans; Male; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors | 1994 |
Experience in advanced prostatic cancer: orchiectomy and flutamide versus orchiectomy and estramustine phosphate.
Topics: Aged; Combined Modality Therapy; Estramustine; Flutamide; Humans; Male; Orchiectomy; Prognosis; Prostatic Neoplasms; Risk Factors; Time Factors | 1994 |
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Castration; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Epirubicin; Estramustine; Flutamide; Humans; Imidazoles; Male; Medroxyprogesterone Acetate; Methotrexate; Mitomycin; Neoplasms, Hormone-Dependent; Procarbazine; Prostatic Neoplasms; Vindesine | 1998 |
Chemohormonal therapy as primary treatment for metastatic prostate cancer: a randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Estramustine; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Probability; Prognosis; Prostatic Neoplasms; Survival Analysis; Treatment Outcome | 2004 |
17 other study(ies) available for flutamide and estramustine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Chemotherapy of advanced prostatic cancer today.
Topics: Aged; Castration; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Estramustine; Fluorouracil; Flutamide; Humans; Male; Megestrol; Middle Aged; Prostatic Neoplasms; Radiotherapy Dosage; Research; Streptozocin | 1976 |
Comparison and significance of respiration and glycolysis of prostatic tissue from various species.
Topics: Animals; Diethylstilbestrol; Dogs; Dose-Response Relationship, Drug; Estramustine; Flutamide; Glycolysis; Haplorhini; Humans; In Vitro Techniques; Macaca; Macaca mulatta; Male; Oxygen Consumption; Papio; Prostate; Prostatic Neoplasms; Rats | 1975 |
Histochemical and ultrastructural study of prostatic tissue from baboons treated with antiprostatic drugs.
Topics: Acid Phosphatase; Aminopeptidases; Anilides; Animals; Atrophy; Diethylstilbestrol; Epithelial Cells; Epithelium; Estramustine; Flutamide; Glucuronidase; Haplorhini; Humans; Male; Nitrogen Mustard Compounds; Papio; Prostate; Prostatic Neoplasms | 1976 |
NK cell activity in treated prostate cancer patients as a probe for circulating tumor cells: hormone regulatory effects in vivo.
Topics: Acid Phosphatase; Antineoplastic Agents; Biomarkers, Tumor; Cyproterone Acetate; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Diethylstilbestrol; Estradiol; Estramustine; Flutamide; Hormones; Humans; Hydrocortisone; Killer Cells, Natural; Male; Orchiectomy; Prolactin; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunoassay; Testosterone | 1992 |
The usefulness of serum acid phosphatase in monitoring patients with advanced prostate carcinoma.
Topics: Alkaline Phosphatase; Biomarkers, Tumor; Bone Neoplasms; Carcinoma; Cyclophosphamide; Estramustine; Estrogens; Flutamide; Follow-Up Studies; Humans; Male; Neoplasm Proteins; Neoplasm Staging; Orchiectomy; Predictive Value of Tests; Prostatic Neoplasms; Treatment Outcome | 1992 |
Neo-adjuvant hormonotherapy does not facilitate radical prostatectomy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Surgical; Chemotherapy, Adjuvant; Cyproterone; Estramustine; Flutamide; Humans; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms | 1992 |
Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay.
Topics: Acid Phosphatase; Antigens, Neoplasm; Antineoplastic Agents; APUD Cells; Biomarkers, Tumor; Carcinoembryonic Antigen; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Flutamide; Humans; Male; Orchiectomy; Phosphopyruvate Hydratase; Prostate-Specific Antigen; Prostatic Neoplasms | 1991 |
Morphologic and immunohistochemical changes in prostate cancer after preoperative hormonal therapy. A comparative study of radical prostatectomies.
Topics: Acid Phosphatase; Adenocarcinoma; Aged; Chemotherapy, Adjuvant; Chromogranin A; Chromogranins; Estramustine; Flutamide; Humans; Immunohistochemistry; Male; Mitosis; Neoplasm Staging; Premedication; Proliferating Cell Nuclear Antigen; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 1994 |
Effect of flutamide withdrawal on response assessment of estramustine and etoposide for prostate cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Estramustine; Etoposide; Flutamide; Humans; Male; Prostatic Neoplasms | 1995 |
Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity.
Topics: Androgen Antagonists; Androgens; Anilides; Animals; Base Sequence; Dihydrotestosterone; Estradiol; Estramustine; Flutamide; Humans; Ligands; Male; Molecular Sequence Data; Nitriles; Phosphorylation; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Tosyl Compounds; Tumor Cells, Cultured | 1999 |
[Malignant priapism as a sign of a recurrent prostate cancer. Differential diagnosis of induratio penis plastica].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Diagnosis, Differential; Drug Therapy, Combination; Epirubicin; Estramustine; Flutamide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Orchiectomy; Palliative Care; Penile Induration; Penile Neoplasms; Priapism; Prostatic Neoplasms; Time Factors | 2003 |
Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Docetaxel; Estramustine; Etoposide; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Nephrostomy, Percutaneous; Nitriles; Phenotype; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Tosyl Compounds; Transurethral Resection of Prostate; Urinary Diversion | 2007 |
[Mediastinal lymph nodes during the course of a metastatic prostate cancer].
Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyproterone; Diphosphonates; Estramustine; Fatal Outcome; Flutamide; Humans; Imidazoles; Ketoconazole; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Radionuclide Imaging; Skin Neoplasms; Triptorelin Pamoate; Zoledronic Acid | 2007 |